Organizations Filed Purposes:
OUR MISSION IS TO LEAD THE WORLD IN TRANSFORMING LIVES TO CREATE A HEALTHY FUTURE FOR INDIVIDUALS & COMMUNITIES THROUGH PREMIER EDUCATIONAL PROGRAMS, INNOVATIVE RESEARCH, & EXTRAORDINARY PATIENT CARE.
Lead the world in transforming lives to create a healthy future for individuals & communities through premier educational programs, innovative research & extraordinary patient care
ONCOLOGY SERVICE LINE CANCER TREATMENT SERVICES OFFERED BY THE CORPORATION INCLUDE TREATMENT OF LYMPHOMA, LEUKEMIA, MULTIPLE MYELOMA, HEAD AND NECK, BREAST, GASTROINTESTINAL, PANCREATIC, LUNG, GENITOURINARY PROSTATE, GYNECOLOGIC, MELANOMA, BRAIN AND SPINE CANCERS. THE PATIENTS ARE SUPPORTED BY RESEARCH THAT IS CONDUCTED ON THE UNMC CAMPUS. TNMC IS THE ONLY CLINICAL CANCER CENTER IN ITS SERVICE AREA DESIGNATED BY THE NATIONAL CANCER INSTITUTE. IN ADDITION TO TREATMENT AND CLINICAL TRIALS TNMC OFFERS SUPPORT GROUPS, SOCIAL WORK, PAIN MANAGEMENT, FINANCIAL COUNSELORS, SUVIVORSHIP GROUPS, GENETIC COUNSELING, AND A VARIETY OF ADDITIONAL PATIENT SUPPORTIVE SERVICES. IN JUNE 2017, TNMC OPENED THE FRED & PAMELA BUFFETT CANCER CENTER. THE CENTER IS JOINTLY OWNED WITH UNMC AND IS ONE OF THE FOREMOST CANCER RESEARCH AND TREATMENT FACILITIES IN THE COUNTRY. IT IS THE SITE OF INPATIENT HOSPITAL CARE, AS WELL AS OUTPATIENT AND DIAGNOSTIC CARE. UNMC'S FACILITIES, WITHIN THE CENTER, HOUSE RESEARCH LABS. TNMC ALSO OPERATES CANCER TREATMENT LOCATIONS IN BELLEVUE, IN WEST OMAHA AT ITS VILLAGE POINTE LOCATION, AND IN SHENANDOAH, IOWA. IN ADDITION, AS ONE OF THE BUSIEST PROGRAMS IN THE WORLD, THE BONE MARROW TRANSPLANTATION PROGRAM SERVED 189 PATIENTS IN THE YEAR ENDED JUNE 30, 2019. A 24/7 EMERGENCY AND EVALUATION TREATMENT CENTER IS DEDICATED TO CANCER AND TRANSPLANT PATIENTS. THE PROGRAM BENEFITS FROM THE RESEARCH CONDUCTED ON TNMC/UNMC CAMPUS. TNMC WAS ONE OF THE FIRST CANCER CENTERS IN THE NATION TO PARTICIPATE IN CLINICAL TRIALS FOR CAR-T CELL THERAPY. IT WAS FDA-APPROVED IN OCTOBER OF 2017. IN AUGUST OF 2018, THE THERAPY WAS EXTENDED TO LEUKEMIA PATIENTS. IN 2019, MULTIPLE MEYELOMA PATIENTS BEGAN RECEIVING THE THERAPY. DURING FISCAL YEAR 2019, THE ONCOLOGY SERVICE LINE TREATED 122,090 CASES AND 30,464 PATIENT DAYS. APPROXIMATELY 40% OF THE NET REVENUE WAS DERIVED FROM INPATIENT CASES.
HEART AND VASCULAR SERVICE LINE TNMC PROVIDES A WIDE RANGE OF CARDIOVASCULAR SERVICES FROM DIET COUNSELING TO SURGICAL PROCEDURES AND REHABILITATION. TNMC HAS GROWN INTO ONE OF THE BUSIEST CENTERS IN THE COUNTRY FOR VENTRICULAR ASSIST DEVICE OPERATIONS. TNMC HAS BEEN SUCCESSFUL IN RECRUITING PHYSICIANS AND HAS THE ONLY HEART FAILURE SPECIALIST IN THE REGION AND THE ONLY HEART FAILURE PROGRAM CERTIFIED BY THE JOINT COMMISSION IN THE STATE OF NEBRASKA. IN 2016, TNMC BEGAN A LUNG TRANSPLANT PROGRAM AND IN DECEMBER OF 2017 PERFORMED THE STATE'S FIRST EVER HEART AND LUNG TRANSPLANT. IN THE YEAR ENDED JUNE 30, 2019, TNMC PERFORMED 6 LUNG TRANSPLANTS. THE CONGESTIVE HEART FAILURE PROGRAM AND ACUTE MYOCARDIAL INFARCTION PROGRAM EACH RECEIVED THE GOLD SEAL OF APPROVAL CERTIFICATION FROM AMERICAN HEART ASSOCIATION AND ARE CERTIFIED BY THE JOINT COMMISSION. THESE SERVICES ARE THE FIRST AND ONLY NATIONALLY CERTIFIED PROGRAMS OF THEIR KIND IN THE STATE OF NEBRASKA. THE CHEST PAIN CENTER HAS RECEIVED FULL CHEST PAIN CENTER ACCREDITATION FROM THE SOCIETY OF CHEST PAIN CENTERS. THE NEBRASKA MEDICAL CENTER HAS BEEN RECOGNIZED FOR SERVICE EXCELLENCE UNDER THE J.D. POWER AND ASSOCIATES DISTINGUISHED HOSPITAL PROGRAM. TNMC HAS THE ONLY JOINT COMMISSION CERTIFIED DESTINATION THERAPY PROGRAM IN THE STATE AND IS THE ONLY HOSPITAL IN THE REGION PERFORMING ADULT HEART TRANSPLANTS AND IMPLANTING TOTAL ARTIFICIALS HEARTS. TNMC TREATS PATIENTS FROM THE SURROUNDING REGION AND IN THE YEAR ENDED JUNE 30, 2019, 819 OPEN HEART SURGERIES WERE PERFORMED INCLUDING: 35 HEART TRANSPLANTS, AND 44 MECHANICAL CIRCULATORY SYSTEMDEVICE IMPLANTATIONS.
DIGESTIVE DISEASE & KIDNEY SERVICE LINE THE NEBRASKA MEDICAL CENTER (TNMC) OPERATES ONE OF THE BUSIEST SOLID ORGAN TRANSPLANT PROGRAMS IN THE WORLD. IN 2016, TNMC JOINED A SMALL NUMBER OF TRANSPLANT CENTERS WHICH HAVE PROGRAMS FOR TRANSPLANTS OF ALL SOLID ORGANS. TNMC'S LUNG TRANSPLANT PROGRAM DID ITS FIRST TRANSPLANT IN FEBRUARY OF 2016 AND PERFORMED 9 LUNG TRANSPLANTS DURING 2019. IN THE YEAR ENDED JUNE 30, 2019, TNMC PERFORMED 279 SOLID ORGAN TRANSPLANTS INCLUDING LIVER, KIDNEY, HEART, LUNG, PANCREAS AND SMALL BOWEL. THE SUCCESS OF TNMC'S SOLID ORGAN TRANSPLANT PROGRAM IS HEIGHTENED BY RESEARCH DONE ON THE TNMC/UNIVERSITY OF NEBRASKA MEDICAL CENTER (UNMC) CAMPUS. SINCE ITS INCEPTION, PATIENTS HAVE COME TO TNMC FOR SINGLE OR MULTIPLE ORGAN TRANSPLANTS FROM ALL 50 STATES AND FIVE CONTINENTS. DURING FISCAL YEAR 2019, THE SOLID ORGAN TRANSPLANTATION SERVICE LINE INCURRED 110,680 CASES AND 29,458 PATIENT DAYS. APPROXIMATELY 67% OF THE REVENUE WAS DERIVED FROM INPATIENT CASES. ALL OTHER HOSPITAL SERVICES WITH A HISTORY DATING BACK TO 1869, TNMC WAS FORMED WITH THE MERGING OF BISHOP CLARKSON MEMORIAL HOSPITAL AND UNIVERSITY HOSPITAL, AND IN JULY, 2016, UNMC PHYSICIANS OUTPATIENT CLINICS BECAME PART OF THE ORGANIZATION. TNMC CONTINUES TO ATTRACT PATIENTS FROM THE REGION AND AROUND THE WORLD. TNMC IS A TERTIARY/QUATERNARY ACADEMIC MEDICAL CENTER. IT IS THE LARGEST HEALTH CARE FACILITY IN THE STATE WITH MORE THAN 10,000 EMPLOYEES AND OVER 900 PHYSICIANS PRACTICING IN ALL MAJOR SPECIALTIES AND SUB-SPECIALTIES. BESIDES SEVERAL KEY SERVICES IN CARDIOLOGY, ONCOLOGY, TRANSPLANT AND NEUROLOGY, TNMC OFFERS COMPREHENSIVE CARE IN WOMEN'S SERVICES FOR OBSTETRICS AND GYNECOLOGY, AS WELL AS PEDIATRIC SERVICES, ORTHOPEDICS, RHEUMATOLOGY, AND PULMONARY CARE. IN ADDITION, TNMC HAS ONE OF THE REGION'S LARGEST HYPERBARIC MEDICINE PROGRAMS. TNMC IS THE MOST ESTEEMED ACADEMIC HEALTH SYSTEMS IN THE REGION, WITH 809 LICENSED BEDS AT ITS TWO HOSPITALS, NEBRASKA MEDICINE - NEBRASKA MEDICAL CENTER, AND NEBRASKA MEDICINE - BELLEVUE. TNMC ALSO OPERATES 40 SPECIALTY AND PRIMARY CARE CLINICS IN OMAHA AND SURROUNDING AREAS. TNMC ALSO HAS ONE OF THE FEW BIOCONTAINMENT UNITS IN THE UNITED STATES EQUIPPED TO SAFELY CARE FOR THOSE EXPOSED TO HIGHLY CONTAGIOUS, DANGEROUS DISEASES. IN SEPTEMBER, OCTOBER, AND NOVEMBER OF 2014, THE NEBRASKA BIOCONTAINMENT UNIT WAS ACTIVATED TO PROVIDE CARE FOR THREE AMERICANS WHO CONTRACTED THE EBOLA VIRUS DURING THE WEST AFRICA OUTBREAK. THIS RESPONSE RESULTED IN TNMC AND UNMC BECOMING ONE OF THREE DESIGNATED EBOLA TREATMENT AND EDUCATION CENTERS IN THE UNITED STATES. BIOCONTAINMENT UNIT STAFF HAVE CONTINUED TO EDUCATE PUBLIC HEALTH AND INFECTIOUS DISEASE TEAMS FROM AROUND THE WORLD ABOUT SAFE PROTOCOLS AND RESPONSES TO INFECTIOUS DISEASES. IN 2020, TNMC AND UNMC WILL OPEN THE NATIONAL CENTER FOR HEALTH SECURITY AND BIOPREPAREDNESS, AS A PART OF THE DAVIS GLOBAL CENTER FOR ADVANCED INTERPROFESSIONAL LEARNING. THIS CENTER WILL BE THE NEXT STEP IN PROVIDING TRAINING ON HOW TO HANDLE HIGHLY INFECTIOUS DISEASES, ALONG WITH A QUARANTINE FACILITY FOR THOSE POSSIBLY INFECTED BY SUCH DISEASES. TNMC ALSO FURTHER SOLIDIFIED ITS ROLE AS A REGIONAL LEADER IN TRAUMA CARE WITH THE ESTABLISHMENT OF ITS 24/7 TRAUMA PROGRAM IN AUGUST OF 2014. IN FYE 2017, TNMC BECAME CERTIFIED AS A LEVEL I TRAUMA CENTER BY THE AMERICAN COLLEGE OF SURGEONS, EARNING THE GOLD STANDARD FOR TRAUMACARE NATIONWIDE. IN 2016, TNMC OPENED THE LAURITZEN OUTPATIENT CENTER ON ITS CAMPUS. THE CENTER PROVIDES ADDITIONAL SPACE FOR CLINCIAL, RESEARCH AND EDUCATIONAL AREAS. THE FRITCH SURGERY CENTER, AS PART OF THIS NEW BUILDING, PROVIDES OUTPATIENT SURGERY PROCEDURES. THE ORGANIZATION CONTINUES ITS COMMITMENT TO PROVIDING CONVENIENT, COMPREHENSIVE CARE IN OMAHA AND THE SURROUNDING COMMUNITIES. IN JULY 2018, A NEW HEALTH CENTER OPENED AT THE UNIVERSITY OF NEBRASKA - LINCOLN, WITH PRIMARY CARE, COUNSELING, PHARMACY, DENTAL, NUTRITION, LAB AND RADIOLOGY, AMONG OTHER SERVICES, FOR STUDENTS OF THE UNIVERSITY. A NEW DERMATOLOGY CLINIC LOCATED ON THE NEBRASKA MEDICAL CENTER CAMPUS OPENED IN SUMMER 2018. IT ADDRESSES A SHORTAGE OF SERVICES IN THE STATE, WITH NEBRASKA HAVING ONE OF THE LOWEST RATIOS OF DERMATOLOGISTS PER RESIDENTS IN THE COUNTRY. IN DECEMBER 2018, THE FONTENELLE HEALTH CENTER, NOW LOCATED AT 5005 AMES AVENUE, WAS RELOCATED TO BETTER SERVE THE NORTH OMAHA COMMUNITY. THE NEBRASKA MEDICAL CENTER OUTPATIENT PHARMACY, LOCATED IN THE DURHAM OUTPATIENT CENTER WAS RENOVATED AND TRIPLED ITS PREVIOUS SIZE. THE NEW SPACE OPENED IN JANUARY 2019. IN MARCH 2019, CLARKSON FAMILY MEDICINE MOVED ITS PRACTICE TO THE NEWLY OPENED Nebraska Medicine OLD MARKET HEALTH CENTER IN DOWNTOWN OMAHA AT 13TH & LEAVENWORTH STREETS. IN FY19, NEBRASKA MEDICAL CENTER EARNED THE FOLLOWING CERTIFICATIONS: - Magnet designation from the American Nurses Credentialing Center - 14 Nebraska Medicine primary care clinics RECOGNIZED as Level III patient-centered medical homes, the highest quality level of achievement FROM The National Committee for Quality Assurance (NCQA) recognized - full accreditation as a Chest Pain Center with Primary PCI (percutaneous coronary intervention) from the American College of Cardiology - LUNG TRANSPLANT PROGRAM CERTIFICATION FROM THE CENTERS FOR MEDICARE AND MEDICAID SERVICES - SAFE SLEEP DESIGNATION FROM THE NEBRASKA DEPARTMENT OF HEALTH AND HUMAN SERVICES - Stage 7 designation, the highest certification for electronic medical record adoption, FOR INPATIENT AND OUTPATIENT PRIMARY CARE FROM THE Health Information and Management System Society
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
Name | Title | Hours Per Week | Total Salary |
Daniel Debehnke | Officer-NM CEO (Thru 8/8/2018) | 45 | $1,607,237 |
Cory D Shaw | Chief Operations Officer | 45 | $757,107 |
Stephanie R Daubert | Officer-NM CFO | 45 | $703,778 |
Frank V Venuto | Chief Human Capital Officer | 45 | $500,834 |
Chadwick Brough | Chief Experience Officer | 55 | $475,569 |
Suzanne Nuss | Chief Nursing Officer | 45 | $453,186 |
Dennis D Bierle | System Clinical Operations COO | 0 | $449,501 |
Theresa Franco | Cancer Ctr/Rad/Imag Svcs VP | 55 | $410,175 |
Thomas C Macy | Amb Clinics/Clinical Prog VP | 55 | $383,159 |
Brian J Lancaster | Information Technology VP | 30 | $376,042 |
Julie Lazure | Acute Care/Path Svcs VP | 55 | $360,578 |
Jennifer L Brown | Staff Physician-Primary | 55 | $354,075 |
James Linder | SEC THRU 8/18; CEO BEG 8/18 | 45 | $348,011 |
Jian Zhao | Faculty Physician | 55 | $332,102 |
Isaac J Berg | Staff Physician-Primary | 55 | $331,709 |
Frank S Lococo | Corp Marketing & Comm VP | 55 | $323,479 |
Matthew E Pospisil | Periop Svs/Bellevue VP | 55 | $312,069 |
Anna Cramer | Chief Legal Officer | 45 | $299,507 |
Louis W Burgher | Director | 40 | $207,328 |
Michael A Ash | EVP/Chief Transformation Ofc | 30 | $0 |
Harris A Frankel | Chief Medical Officer | 10 | $0 |
Carl V Smith | Director (thru 10/2/2018) | 30 | $0 |
David W Mercer | Director | 30 | $0 |
Debra Romberger | Director | 30 | $0 |
James E Mcclurg | Director | 1 | $0 |
Eric K Keen | Director | 1 | $0 |
Lance M Fritz | Director | 1 | $0 |
James T Canedy | Director | 1 | $0 |
Nancy Keegan | Secretary (Start 10/2/2018) | 1 | $0 |
Bruce Grewcock | DIRECTOR (TREASURER) | 1 | $0 |
Mogens Bay | DIRECTOR (VICE CHAIRMAN) | 1 | $0 |
Jeffrey Gold | DIRECTOR (CHAIRMAN) | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202001929349302025_public.xml